Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Scedosporium Infection”

7 trials

Showing 7 of 7 results

Testing effectiveness (Phase 2)Ended earlyNCT04240886
What this trial is testing

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica 21
Large-scale testing (Phase 3)Ended earlyNCT00836875
What this trial is testing

Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

Who this might be right for
Invasive Aspergillosis
Pfizer 31
Testing effectiveness (Phase 2)Study completedNCT03583164
What this trial is testing

Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options

Who this might be right for
Invasive Fungal Infections
F2G Biotech GmbH 203
Not applicableStudy completedNCT01660334
What this trial is testing

Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)

Who this might be right for
Scedosporium Infection
Pfizer 13
Not applicableLooking for participantsNCT06285188
What this trial is testing

Immunomonitoring of Mold Invasive Infections

Who this might be right for
Invasive Fungal DiseaseMold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium
Assistance Publique - Hôpitaux de Paris 20
Early research (Phase 1)Study completedNCT05491733
What this trial is testing

A Bioequivalence Study of APX001 High-load and Low-load Tablets

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica 18
Large-scale testing (Phase 3)Looking for participantsNCT06925321
What this trial is testing

Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

Who this might be right for
Invasive Mold Infections
Basilea Pharmaceutica 234

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation